RUBIUS THERAPEUTICS INC (RUBY)
US78116T1034 - Common Stock
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -179.67M | -196.55M | -167.73M | -163.46M | -89.20M | |||
| Depreciation Amortization | 6.25M | 7.72M | 5.69M | 3.00M | 1.26M | |||
| Change In Working Capital | -17.52M | 6.69M | 110.00K | 10.44M | 120.00K | |||
| Interest Paid | 4.39M | 5.09M | 3.82M | 2.96M | 390.00K | |||
| Other non cash items | 40.80M | 37.01M | 34.28M | 39.58M | 29.47M | |||
| OPERATING CASH FLOW | -150.14M | -145.12M | -127.65M | -110.44M | -58.34M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.30M | -3.65M | -5.50M | -40.66M | -14.95M | |||
| Other Investing Activity | 18.25M | 85.00M | 105.93M | -91.98M | -96.69M | |||
| INVESTING CASH FLOW | 12.94M | 81.35M | 100.43M | -132.64M | -111.64M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -75.70M | 0.00 | 25.00M | 25.00M | 19.75M | |||
| Stock Issued/Repurchased | 232.00K | 198.96M | 1.48M | 2.29M | 358.92M | |||
| Other Financing Activity | 0.00 | -510.00K | 0.00 | 0.00 | -3.83M | |||
| FINANCING CASH FLOW | -75.47M | 198.45M | 26.48M | 27.29M | 374.83M | |||
| CHANGE IN CASH | -212.67M | 134.68M | -740.00K | -215.79M | 204.85M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -150.14M | -145.12M | -127.65M | -110.44M | -58.34M | |||
| Capital Expenditure | -5.30M | -3.65M | -5.50M | -40.66M | -14.95M | |||
| FREE CASH FLOW | -155.45M | -148.77M | -133.15M | -151.10M | -73.29M | |||
All data in USD